APA aipamena

Newman, J., Seetharamu, N., & Saif, M. W. (2020). Burden of Proof: Evaluating the Efficacy of Tumor Mutational Burden (TMB) in Predicting Response to Immune Checkpoint Inhibitors. Cancer Med J.

Chicago Style aipamena

Newman, James, Nagashree Seetharamu, and Muhammad Wasif Saif. "Burden of Proof: Evaluating the Efficacy of Tumor Mutational Burden (TMB) in Predicting Response to Immune Checkpoint Inhibitors." Cancer Med J 2020.

MLA aipamena

Newman, James, Nagashree Seetharamu, and Muhammad Wasif Saif. "Burden of Proof: Evaluating the Efficacy of Tumor Mutational Burden (TMB) in Predicting Response to Immune Checkpoint Inhibitors." Cancer Med J 2020.